264 related articles for article (PubMed ID: 23316289)
21. Left atrial catheter ablation subsequent to Watchman® left atrial appendage device implantation: a single centre experience.
Walker DT; Phillips KP
Europace; 2015 Sep; 17(9):1402-6. PubMed ID: 25999186
[TBL] [Abstract][Full Text] [Related]
22. Left atrial appendage electrical isolation and concomitant device occlusion: A safety and feasibility study with histologic characterization.
Panikker S; Virmani R; Sakakura K; Kolodgie F; Francis DP; Markides V; Walcott G; McElderry HT; Wong T
Heart Rhythm; 2015 Jan; 12(1):202-10. PubMed ID: 25239429
[TBL] [Abstract][Full Text] [Related]
23. Mid-term outcomes of concomitant left atrial appendage closure and catheter ablation for non-valvular atrial fibrillation: a multicenter registry.
Liu FZ; Lin WD; Liao HT; Peng J; Xue YM; Zhan XZ; Zhu JM; Yiu KH; Li YF; Tse HF; Shi L; Fang XH; Wu SL
Heart Vessels; 2019 May; 34(5):860-867. PubMed ID: 30599061
[TBL] [Abstract][Full Text] [Related]
24. Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation.
Liu J; Xia Y; Zhang H; Li X; Zhang S; Fang P
Herz; 2021 Apr; 46(Suppl 1):82-88. PubMed ID: 32002565
[TBL] [Abstract][Full Text] [Related]
25. Reduced Incidence of Thromboembolic Events After Surgical Closure of Left Atrial Appendage in Patients With Atrial Fibrillation.
Wilbring M; Jung F; Weber C; Matschke K; Knaut M
Innovations (Phila); 2016; 11(1):24-30; discussion 30. PubMed ID: 26914669
[TBL] [Abstract][Full Text] [Related]
26. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation.
Sick PB; Schuler G; Hauptmann KE; Grube E; Yakubov S; Turi ZG; Mishkel G; Almany S; Holmes DR
J Am Coll Cardiol; 2007 Apr; 49(13):1490-5. PubMed ID: 17397680
[TBL] [Abstract][Full Text] [Related]
27. One-stop strategy for treatment of atrial fibrillation: feasibility and safety of combining catheter ablation and left atrial appendage closure in a single procedure.
Chen M; Wang ZQ; Wang QS; Sun J; Zhang PP; Feng XF; Li W; Yu Y; Liu B; Mo BF; Zhang R; Yang M; Gong CQ; Zhao MZ; Yu YC; Zhao Y; Lu QF; Li YG
Chin Med J (Engl); 2020 Jun; 133(12):1422-1428. PubMed ID: 32433041
[TBL] [Abstract][Full Text] [Related]
28. Optimal combination strategy of left atrial appendage closure plus catheter ablation in a single procedure in patients with nonvalvular atrial fibrillation.
Du X; Chu H; He B; Wang B; Liu J; Feng M; Yu Y; Fu G; Jin H; Gao F; Zhu J; Chen X
J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1089-1095. PubMed ID: 29727507
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy analysis of one-stop intervention for treating nonvalvular atrial fibrillation.
Hu H; Cui K; Jiang J; Fu H; Zeng R
Pacing Clin Electrophysiol; 2018 Jan; 41(1):28-34. PubMed ID: 29194654
[TBL] [Abstract][Full Text] [Related]
30. The WATCHMAN left atrial appendage closure device for atrial fibrillation.
Möbius-Winkler S; Sandri M; Mangner N; Lurz P; Dähnert I; Schuler G
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22395336
[TBL] [Abstract][Full Text] [Related]
31. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
[TBL] [Abstract][Full Text] [Related]
32. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
[TBL] [Abstract][Full Text] [Related]
33. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
Onalan O; Crystal E
Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
[TBL] [Abstract][Full Text] [Related]
34. Exclusion of electrical and mechanical function of the left atrial appendage in patients with persistent atrial fibrillation: differences in efficacy and safety between endocardial ablation vs epicardial LARIAT ligation (the EXCLUDE LAA study).
Parikh V; Rasekh A; Mohanty S; Yarlagadda B; Atkins D; Bommana S; Turagam M; Jeffery C; Carroll H; Nydegger C; Jaeger M; Dar T; Cheng J; Gopinnathanair R; Dibiase L; Lee R; Horton R; Natale A; Lakkireddy D
J Interv Card Electrophysiol; 2020 Apr; 57(3):409-416. PubMed ID: 31863251
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Foley D; Sievert H; Mazzone P; De Potter T; Vireca E; Stein K; Bergmann MW;
Heart Rhythm; 2017 Sep; 14(9):1302-1308. PubMed ID: 28577840
[TBL] [Abstract][Full Text] [Related]
37. The prevalence and characteristics of candidates for percutaneous left atrial appendage occlusion using a WATCHMAN device among patients who underwent atrial fibrillation ablation in a Japanese population.
Kemi Y; Yamashita E; Fujiwara T; Kario K; Sasaki T; Minami K; Miki Y; Goto K; Take Y; Nakamura K; Naito S
J Echocardiogr; 2021 Dec; 19(4):243-249. PubMed ID: 34296416
[TBL] [Abstract][Full Text] [Related]
38. Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation.
Chen S; Chun KRJ; Bordignon S; Weise FK; Nagase T; Perrotta L; Bologna F; Schmidt B
J Cardiol; 2019 Apr; 73(4):299-306. PubMed ID: 30583991
[TBL] [Abstract][Full Text] [Related]
39. Cryoballoon Ablation and Bipolar Voltage Mapping in Patients With Left Atrial Appendage Occlusion Devices.
Huang HD; Krishnan K; Sharma PS; Kavinsky CJ; Rodriguez J; Ravi V; Larsen TR; Trohman RG
Am J Cardiol; 2020 Nov; 135():99-104. PubMed ID: 32866447
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and Safety of Left Atrial Appendage Closure Using the LAmbre Device in Patients with Nonvalvular Atrial Fibrillation with or Without Prior Catheter Ablation.
Feng XF; Zhang PP; Sun J; Wang QS; Li YG
Int Heart J; 2019 Jan; 60(1):63-70. PubMed ID: 30464131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
